07 November 2025
07 November 2025
James Watson was an outstanding figure in science, having carried out crucial work in the discovery of the structure of DNA, which earned him the Nobel Prize in Physiology or Medicine in 1962. His essential discoveries in the field of biology were decisive in shaping the course of Science as we know it today.
06 November 2025
Historically, scientists studying the brain, like neuroscientists and psychologists, worked separately from those studying the body, such as endocrinologists and physiologists. Research on how the nervous system interacts with the body has been growing, but “it kind of stops there, rarely making it past the neck to reach the brain again”, as Carlos Ribeiro puts it. Neuroscientists, meanwhile, often focus on higher brain functions without considering how body signals might influence them.
30 Oct. 2025
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a PhD Student to join our team at the Champalimaud Research Program.
27 October 2025
Cheese and chocolate might not tempt a fruit fly’s palate, but to a hungry fly short on nutrients, their smell carries a hidden signal. When deprived of certain amino acids – the building blocks of protein – these tiny insects develop a surprisingly refined sense of smell that helps them track down not just food, but specific bacteria living in fermented foods.
24 October 2025
With nearly 30 presenters, including four keynote speakers, and over 300 participants from across the globe, the symposium was structured into multiple sessions exploring different themes. Chaired by CF’s Memming Park, Principal Investigator of the Neural Dynamics Lab, together with Yale University’s Shreya Saxena and the University of Cambridge’s Guillaume Hennequin, the event focused on neurocybernetics – a field first defined in the 1940s that studies how brains use feedback and control to adapt, learn, and interact with their surroundings.
23 October 2025
“I was a psychedelic teenager. Then, at 18, I had a bad trip with LSD, and became very paranoid”, explained Jules Evans to his audience at the event that took place at Champalimaud Foundation, at the beginning of the month, under the title “Psychedelic Therapy: From Evidence to Equity”. Today, Evans is the founder and Director of the Challenging Psychedelic Experiences Project, the leading resource for post-psychedelic difficulties and what helps people recover from them.